Author Archives: wesley

Policy Analysis and Guidance: Guizhou’s Notification on Guiding and Regulating Private Hospital Development

Guizhou Province’s Health Commission, Medical Insurance Bureau, and Traditional Chinese Medicine Bureau have issued a notification to further guide and regulate the development of private hospitals. This policy aims to promote the healthy, standardized development of private hospitals, enhance medical service quality, and meet the diverse health needs of the public.

Key Policy Highlights

Strengthening Party Leadership
- Organizational Coverage: Expand party organization coverage in private hospitals, establishing separate or joint party organizations based on the number of formal party members.
- Political Core Role: Play the role of party organizations as a political core, ensuring the implementation of party policies and promoting high-quality development through strengthened ideological, cultural, and anti-corruption work.
Regulating Practice Behavior
- Name Standardization: Prohibition misleading names and reserve certain titles exclusive for public healthcare institutions.
- Approval and Verification: Improve approval efficiency and encourage participation in hospital grading evaluations.
- Department Setup: Align department setup with practice scopes and qualifications, prohibiting misleading or unconventional department names.
- Personnel Qualifications: Ensure all medical staff are properly qualified and registered, with a focus on building a structured talent pool.
Enhancing Service Quality
- Quality and Safety Management: Integrate private hospitals into the medical quality management system and establish real-time supervision mechanisms.
- Clinical Technology Application: Standardize the management of medical technologies and surgeries through established directories and dynamic assessments.
- Pharmaceutical and Device Management: Ensure the safety and quality of药品and medical devices, with strict management of high-risk items and traditional Chinese medicine.
- Infection Control: Strengthen hospital infection management through comprehensive systems and staff training.
Supporting Healthy Development
- Specialized Development Guidance: Encourage private hospitals to focus on specialized fields and innovative service models.
- Talent and Specialized Development Support: Provide equal opportunities for private hospital professionals in title evaluations and training.
- Medical Alliance Participation: Support private hospitals in joining medical alliances to promote resource sharing and coordinated development.
- Medical Insurance Policy Support: Facilitate private hospitals’ participation in drug and device procurement and medical insurance services.
Comprehensive Regulation
- Risk Prevention: Establish comprehensive risk management systems to enhance medical safety.
- Regulatory Enforcement: Use various inspection methods to ensure compliance with medical practice and safety standards.
- Information Transparency: Enhance Hospital Information Disclosure Systems to Ensure Accuracy and Prevent Misleading Promotion.
- Credit Evaluation: Implement a credit evaluation system for private hospitals to promote trust and regulatory efficiency.

Policy Orientation and Industry Implications
Guizhou’s policy on guiding and regulating private hospitals reflects a strategic focus on:

Quality Enhancement: Improving medical service quality through rigorous standards and management.
Regulatory Efficiency: Strengthening oversight to ensure compliance and patient safety.
Industry Support: Promoting sustainable growth and innovation in the private hospital sector.

Conclusion
Guizhou’s comprehensive approach to private hospital regulation and support sets a benchmark for regional healthcare management, emphasizing quality, compliance, and industry development. Private hospitals should align with these guidelines to enhance service quality, build public trust, and achieve sustainable growth.-China Health Reform Pulse

Policy Source: https://wjw.guizhou.gov.cn/zwgk/gzhgfxwjsjk/gfxwjsjk/202504/t20250401_87326150.html

Policy Analysis and Guidance: Guangdong Province’s Volume-Based Drug Procurement Initiative

Guangdong Province’s Drug Exchange Center has issued a notice outlining the implementation details of the centralized volume-based procurement initiative for medications such as Apixaban tablets. This policy, effective from April 1, 2025, to December 31, 2025, aims to streamline drug procurement processes, enhance supply chain stability, and ensure quality assurance across healthcare institutions.

Key Policy Measures

Tripartite Contract Signing
- Process: Medical institutions must use CA certificates to log into Guangdong’s tender and procurement subsystem to initiate tripartite contracts. Detailed operational guidance is available on the official website.
- Timeline: Contracts must be completed promptly after initiation by medical institutions, with drug manufacturers and distributors required to log in and finalize agreements without delay.
Quality and Supply Responsibility
- Accountability: Drug manufacturers are designated as the primary responsible parties for ensuring the quality and timely delivery of medications. They must guarantee coverage of all participating healthcare institutions across the province.
- Compliance: Selected manufacturers must adhere to agreed-upon procurement volumes and ensure uninterrupted supply chains.
Procurement Volume Negotiation
- Flexibility: For designated social healthcare institutions, procurement volumes will be determined through negotiations between supply and demand parties, allowing for tailored agreements.

Policy Orientation and Industry Implications
This initiative reflects Guangdong’s strategic focus on:

Cost Efficiency: Reducing drug prices through centralized procurement while maintaining quality standards.
Supply Chain Integrity: Ensuring uninterrupted medication supply to healthcare facilities across the province.
Transparency: Promoting clear contractual agreements and accountability mechanisms.

Conclusion
Guangdong’s volume-based procurement framework sets a benchmark for regional drug management, emphasizing efficiency, quality, and accessibility. Stakeholders, including manufacturers, distributors, and healthcare providers, should align their operations with these guidelines to optimize compliance and patient outcomes.-China Health Reform Pulse

Policy Source: https://www.gdmede.com.cn/announcement/announcement/detail?id=1906642648857317376

Policy Analysis and Guidance: Sichuan’s Medical Device Export Sales Certification Announcement

Sichuan Provincial Drug Administration has released the Medical Device Export Sales Certification Information Announcement (Issue 9, 2025). This initiative aims to provide transparent and accurate information on medical device exports, supporting international market access and enhancing the global competitiveness of domestic medical device enterprises.

Key Policy Highlights

Certification Information Disclosure
- Purpose: To provide the public and international markets with accurate information on certified medical devices.
- Details: The announcement includes detailed certification information for multiple medical device companies, such as Sichuan Bomestar Dental Equipment Co., Ltd.
Regulatory Compliance
- Standards: Ensuring all exported medical devices comply with national standards and regulations.
- Transparency: Making certification information publicly available to enhance trust and facilitate international trade.
International Market Support
- Development: Supporting the international expansion of the medical device industry through clear and efficient certification processes.
- Efficiency: Streamlining the certification process to reduce administrative burdens and promote industry growth.

Policy Orientation and Industry Implications
The export sales certification policy reflects Sichuan’s strategic focus on:

Transparency: Ensuring public and international access to accurate certification information.
Compliance: Strengthening regulatory frameworks to ensure product safety and quality.
Global Competitiveness: Supporting the international development of the medical device sector.

Conclusion
Sichuan’s approach to medical device export sales certification sets a benchmark for regional medical device regulation, emphasizing transparency, compliance, and global competitiveness. Medical device enterprises should align with these guidelines to ensure smooth international operations and build global trust.-China Health Reform Pulse

Policy Source: http://yjj.sc.gov.cn/scyjj/c103180/2025/3/31/8af3a8ea68e1418e93cbeb6915ed4ce7.shtml